The 89.5% market-implied probability against a new pandemic in 2026 reflects the absence of any novel pathogen demonstrating sustained global human-to-human transmission, according to current WHO and CDC surveillance data. Ongoing monitoring of known threats, including H5N1 avian influenza and mpox clade IIb, shows only sporadic cases without exponential growth or emergency declarations. Recent contained incidents, such as limited hantavirus clusters, further align with this assessment. Post-COVID improvements in genomic sequencing, wastewater surveillance, and international reporting have strengthened early detection, reducing the chance of undetected emergence through the remainder of the year. Traders view these conditions as consistent with historical patterns where pandemics arise from rare zoonotic spillovers that rapidly amplify.